Craig Adam R, Executive Chairman of X4 Pharmaceuticals ($XFOR), made one open market purchase of company shares in the last year, totaling about $250,000, with the most recent on October 23, 2025. This ranks him 1,347th among nearly 5,000 individual insiders by purchase amount, below the average of $1.5 million across 3.3 transactions. He reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 29, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Craig Adam R | Executive Chairman | A | Stock Option (right to buy) | 2329154 | $0.00 | 2,329,154.0000 | 43,272,773 | 9999.99% | 5.38% |
| Oct. 23, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Craig Adam R | Executive Chairman | P | Common Stock | 86206 | $2.90 | 376,087.0000 | 43,272,773 | 29.74% | 0.20% |
| Aug. 14, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Craig Adam R | Executive Chairman | A | Common Stock | 289881 | $0.00 | 289,881.0000 | 201,062,211 | 9999.99% | 0.14% |
| Aug. 12, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Craig Adam R | Executive Chairman | A | Stock Option (right to buy) | 1609873 | $0.00 | 1,609,873.0000 | 201,062,211 | 9999.99% | 0.80% |
| Aug. 14, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Craig Adam R | Executive Chairman | A | Stock Option (right to buy) | 529201 | $0.00 | 529,201.0000 | 201,062,211 | 9999.99% | 0.26% |